Olanzapine
Showing 26 - 50 of 634
Resistant Schizophrenia From the Illness Onset
Not yet recruiting
- Treatment-resistant Schizophrenia
- risperidone, olanzapine, aripiprazole
- (no location specified)
Nov 7, 2023
Postoperative Nausea, Postoperative Nausea and Vomiting Trial in Sao Paulo (Olanzapine)
Completed
- Postoperative Nausea
- Postoperative Nausea and Vomiting
- Olanzapine
-
Sao Paulo, São Paulo, BrazilCancer Institute of the State of Sao Paulo - ICESP
Jan 11, 2022
Nausea Post Chemo Trial in São Paulo (Olanzapine, Netupitant, Palonesetron)
Completed
- Nausea Post Chemotherapy
- Olanzapine
- +2 more
-
São Paulo, BrazilIBCC Oncologia
Feb 7, 2022
Headache Trial in Saint Paul (Standard of Care as per attending physician, 5mg rapidly dissolving olanzapine)
Completed
- Headache
- Standard of Care as per attending physician
- 5mg rapidly dissolving olanzapine
-
Saint Paul, MinnesotaRegions Hospital
Jan 2, 2022
Delirium, Terminal Illness Trial in Singapore (Haloperidol Solution, Olanzapine Tablets)
Recruiting
- Delirium
- Terminal Illness
- Haloperidol Solution
- Olanzapine Tablets
-
Singapore, SingaporeHCA Hospice Care
Dec 20, 2021
Schizophrenia Trial (Olanzapine, Asenapine, Placebo)
Completed
- Schizophrenia
- Olanzapine
- +2 more
- (no location specified)
Feb 4, 2022
Schizophrenia Trial in Catonsville (Diet support group, Group counseling and exercise)
Completed
- Schizophrenia
- Diet support group
- Group counseling and exercise
-
Catonsville, MarylandMaryland Psychiatric Research Center
Mar 1, 2022
![](/image/sponsor/joint_stock_company_"farmak")
Pharmacokinetics Trial in Prague (Olanzapine film-coated tablets 5 mg (JSC Farmak, Ukraine), Zyprexa® coated tablets 5 mg (Eli
Completed
- Pharmacokinetics
- Olanzapine film-coated tablets 5 mg (JSC Farmak, Ukraine)
- Zyprexa® coated tablets 5 mg (Eli Lilly, Nederland B V)
-
Prague, CzechiaQUINTA-ANALYTICA s.r.o.
Nov 15, 2021
Gynecologic Cancer Trial in Ann Arbor (Ondansetron, Dexamethasone, Neurokinin-1 Receptor Antagonist (NK1-RA))
Recruiting
- Gynecologic Cancer
- Ondansetron
- +4 more
-
Ann Arbor, MichiganUniversity of Michigan Rogel Cancer Center
Jan 6, 2022
Schizophrenia, Schizoaffective Disorder Trial (asenapine, olanzapine)
Completed
- Schizophrenia
- Schizoaffective Disorder
- asenapine
- olanzapine
- (no location specified)
Feb 7, 2022
Adverse Effect of Other Antipsychotics and Neuroleptics, Insulin Resistance Trial in Detroit (olanzapine, )
Active, not recruiting
- Adverse Effect of Other Antipsychotics and Neuroleptics
- Insulin Resistance
- olanzapine
- placebo
-
Detroit, MichiganWayne State University Clinical Research Center
Jul 11, 2022
Clinical Response in Substance Use Disorder
Recruiting
- Substance Use Disorders
- Substance Dependence
- Quetiapine, olanzapine, mirtazapine, carbamazepine, sertraline, amitriptyline, chlorpromazine and risperidone
-
Alexandria, EgyptAlexandria University
Apr 16, 2023
Panic Disorder Trial (Hydroxyzine, Escitalopram Oxalate)
Not yet recruiting
- Panic Disorder
- Hydroxyzine
- Escitalopram Oxalate
- (no location specified)
Feb 20, 2023
Breast Cancer Trial in Hong Kong (Experimental drug: Aprepitant, Experimental drug: Ondansetron, Experimental drug:
Completed
- Breast Cancer
- Experimental drug: Aprepitant
- +6 more
-
Hong Kong, Hong KongDepartment of Clinical Oncology, Prince of Wales Hospital
Jul 26, 2021